chr2-25300185-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBS2_Supporting
The NM_022552.5(DNMT3A):c.131C>T(p.Thr44Met) variant causes a missense change. The variant allele was found at a frequency of 0.000049 in 1,612,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_022552.5 missense
Scores
Clinical Significance
Conservation
Publications
- Tatton-Brown-Rahman overgrowth syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Heyn-Sproul-Jackson syndromeInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022552.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DNMT3A | NM_022552.5 | MANE Select | c.131C>T | p.Thr44Met | missense | Exon 3 of 23 | NP_072046.2 | ||
| DNMT3A | NM_175629.2 | c.131C>T | p.Thr44Met | missense | Exon 3 of 23 | NP_783328.1 | |||
| DNMT3A | NM_001320892.2 | c.131C>T | p.Thr44Met | missense | Exon 3 of 4 | NP_001307821.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DNMT3A | ENST00000321117.10 | TSL:1 MANE Select | c.131C>T | p.Thr44Met | missense | Exon 3 of 23 | ENSP00000324375.5 | ||
| DNMT3A | ENST00000264709.7 | TSL:1 | c.131C>T | p.Thr44Met | missense | Exon 3 of 23 | ENSP00000264709.3 | ||
| DNMT3A | ENST00000406659.3 | TSL:1 | c.131C>T | p.Thr44Met | missense | Exon 3 of 4 | ENSP00000384852.3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000963 AC: 24AN: 249336 AF XY: 0.000111 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460548Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 726694 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152284Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74458 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
DNMT3A-related disorder Uncertain:1
The DNMT3A c.131C>T variant is predicted to result in the amino acid substitution p.Thr44Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.075% of alleles in individuals of East Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Tatton-Brown-Rahman overgrowth syndrome Benign:1
not specified Other:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at